Millennium Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.44M | Sell |
118,500
-107,100
| -47% | -$7.46M | ﹤0.01% | 2491 |
|
|
2025
Q4 | $15M | Buy |
225,600
+115,500
| +105% | +$7.47M | 0.01% | 1841 |
|
|
2025
Q3 | $7.41M | Buy |
110,100
+21,600
| +24% | +$1.71M | ﹤0.01% | 2708 |
|
|
2025
Q2 | $7.73M | Sell |
88,500
-55,200
| -38% | -$4.33M | ﹤0.01% | 2540 |
|
|
2025
Q1 | $9.81M | Sell |
143,700
-18,400
| -11% | -$1.5M | 0.01% | 2216 |
|
|
2024
Q4 | $12.6M | Sell |
162,100
-228,700
| -59% | -$16.9M | 0.01% | 1961 |
|
|
2024
Q3 | $26.2M | Buy |
390,800
+354,500
| +977% | +$29.1M | 0.01% | 1307 |
|
|
2024
Q2 | $4.12M | Sell |
36,300
-141,100
| -80% | -$17.8M | ﹤0.01% | 2895 |
|
|
2024
Q1 | $24.6M | Buy |
177,400
+15,800
| +10% | +$1.99M | 0.01% | 1382 |
|
|
2023
Q4 | $20.1M | Sell |
161,600
-17,400
| -10% | -$1.78M | 0.01% | 1539 |
|
|
2023
Q3 | $16.7M | Sell |
179,000
-235,900
| -57% | -$26.6M | 0.01% | 1583 |
|
|
2023
Q2 | $53.3M | Buy |
414,900
+153,700
| +59% | +$18.6M | 0.03% | 694 |
|
|
2023
Q1 | $30.3M | Sell |
261,200
-313,900
| -55% | -$35.1M | 0.02% | 1014 |
|
|
2022
Q4 | $65.1M | Buy |
575,100
+95,800
| +20% | +$10.5M | 0.04% | 600 |
|
|
2022
Q3 | $38.6M | Buy |
479,300
+41,900
| +10% | +$3.55M | 0.02% | 840 |
|
|
2022
Q2 | $32.6M | Buy |
437,400
+157,400
| +56% | +$14.4M | 0.02% | 898 |
|
|
2022
Q1 | $35.8M | Buy |
280,000
+94,000
| +51% | +$10.3M | 0.02% | 903 |
|
|
2021
Q4 | $25M | Buy |
186,000
+129,200
| +227% | +$18.6M | 0.01% | 1244 |
|
|
2021
Q3 | $7.76M | Sell |
56,800
-277,200
| -83% | -$35M | ﹤0.01% | 2368 |
|
|
2021
Q2 | $35.7M | Sell |
334,000
-88,800
| -21% | -$8.53M | 0.02% | 787 |
|
|
2021
Q1 | $38M | Buy |
422,800
+346,800
| +456% | +$32.6M | 0.03% | 647 |
|
|
2020
Q4 | $7.03M | Sell |
76,000
-51,200
| -40% | -$4.57M | 0.01% | 2117 |
|
|
2020
Q3 | $13.1K | Buy |
127,200
+87,200
| +218% | +$9.11M | 0.02% | 1051 |
|
|
2020
Q2 | $4.05M | Sell |
40,000
-8,000
| -17% | -$716K | 0.01% | 1960 |
|
|
2020
Q1 | $3.23M | Buy |
48,000
+28,000
| +140% | +$1.74M | 0.01% | 1673 |
|
|
2019
Q4 | $1.09M | Sell |
20,000
-20,000
| -50% | -$949K | ﹤0.01% | 2963 |
|
|
2019
Q3 | $1.49M | Buy |
40,000
+10,000
| +33% | +$389K | ﹤0.01% | 2631 |
|
|
2019
Q2 | $1.12M | Sell |
30,000
-130,000
| -81% | -$4.09M | ﹤0.01% | 2731 |
|
|
2019
Q1 | $4.76M | Buy |
160,000
+80,000
| +100% | +$2.81M | 0.01% | 1802 |
|
|
2018
Q4 | $2.4M | Buy |
80,000
+40,000
| +100% | +$1.27M | ﹤0.01% | 2088 |
|
|
2018
Q3 | $1.43M | Hold |
40,000
| – | – | ﹤0.01% | 2661 |
|
|
2018
Q2 | $950K | Sell |
40,000
-40,000
| -50% | -$848K | ﹤0.01% | 2869 |
|
|
2018
Q1 | $1.48M | Buy |
+80,000
| New | +$1.18M | ﹤0.01% | 2488 |
|
Other funds holding DXCM
VCM
VPM
Millennium Management's DXCM Position: Q1 2026 in Review
Millennium Management increased its DexCom (DXCM) stake by 2% in Q1 2026, buying an estimated $2.25M and bringing the position to 1,622,204 shares worth $102M. The position accounts for 0.04% of the portfolio, ranked #436.
Millennium Management first reported a position in DXCM in Q2 2013 and has held it in 50 quarters since. The position peaked at $441M in Q4 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Millennium Management held 1,622,204 shares of DexCom worth $102M as of Q1 2026.
- Millennium Management bought 32,327 DexCom shares in Q1 2026, an estimated $2.25M.
- DexCom made up 0.04% of Millennium Management's portfolio in Q1 2026, its #436 holding.
- Millennium Management first reported a position in DexCom in Q2 2013 and has held it in 50 quarters since.
- Millennium Management's DexCom position peaked at $441M in Q4 2022.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.